These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 21684423)
1. Establishment of pandemic influenza vaccine production capacity at Bio Farma, Indonesia. Suhardono M; Ugiyadi D; Nurnaeni I; Emelia I Vaccine; 2011 Jul; 29 Suppl 1():A22-5. PubMed ID: 21684423 [TBL] [Abstract][Full Text] [Related]
2. Development of influenza vaccine production capacity by the Government Pharmaceutical Organization of Thailand: addressing the threat of an influenza pandemic. Surichan S; Wirachwong P; Supachaturas W; Utid K; Theerasurakarn S; Langsanam P; Lakornrach P; Nitisaporn L; Chansikkakorn C; Vangkanonta W; Kaweepornpoj R; Poopipatpol K; Thirapakpoomanunt S; Srichainak S; Artavatkun W; Chokevivat V; Wibulpolprasert S Vaccine; 2011 Jul; 29 Suppl 1():A29-33. PubMed ID: 21684425 [TBL] [Abstract][Full Text] [Related]
3. United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world. Perdue ML; Bright RA Vaccine; 2011 Jul; 29 Suppl 1():A48-50. PubMed ID: 21684430 [TBL] [Abstract][Full Text] [Related]
4. Development of pandemic influenza vaccine production capacity in Viet Nam. Hoa LK; Hiep LV; Be LV Vaccine; 2011 Jul; 29 Suppl 1():A34-6. PubMed ID: 21684426 [TBL] [Abstract][Full Text] [Related]
5. WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer. Friede M; Palkonyay L; Alfonso C; Pervikov Y; Torelli G; Wood D; Kieny MP Vaccine; 2011 Jul; 29 Suppl 1():A2-7. PubMed ID: 21684422 [TBL] [Abstract][Full Text] [Related]
6. A pandemic influenza vaccine in India: from strain to sale within 12 months. Dhere R; Yeolekar L; Kulkarni P; Menon R; Vaidya V; Ganguly M; Tyagi P; Barde P; Jadhav S Vaccine; 2011 Jul; 29 Suppl 1():A16-21. PubMed ID: 21684421 [TBL] [Abstract][Full Text] [Related]
7. Domestic influenza vaccine production in Mexico: a state-owned and a multinational company working together for public health. Ponce-de-Leon S; Velazquez-Fernandez R; Bugarin-González J; García-Bañuelos P; Lopez-Sotelo A; Jimenez-Corona ME; Padilla-Catalan F; Cervantes-Rosales R Vaccine; 2011 Jul; 29 Suppl 1():A26-8. PubMed ID: 21684424 [TBL] [Abstract][Full Text] [Related]
8. Influenza vaccine production for Brazil: a classic example of successful North-South bilateral technology transfer. Miyaki C; Meros M; Precioso AR; Raw I Vaccine; 2011 Jul; 29 Suppl 1():A12-5. PubMed ID: 21684420 [TBL] [Abstract][Full Text] [Related]
9. [Influenza vaccine: globalization of public health stakes]. Collin N; Briand S Med Trop (Mars); 2009 Aug; 69(4):322. PubMed ID: 19725377 [TBL] [Abstract][Full Text] [Related]
10. An international technology platform for influenza vaccines. Hendriks J; Holleman M; de Boer O; de Jong P; Luytjes W Vaccine; 2011 Jul; 29 Suppl 1():A8-11. PubMed ID: 21684431 [TBL] [Abstract][Full Text] [Related]
11. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza. Collin N; de Radiguès X; Vaccine; 2009 Aug; 27(38):5184-6. PubMed ID: 19563891 [TBL] [Abstract][Full Text] [Related]
12. WHO influenza vaccine technology transfer initiative: role and activities of the Technical Advisory Group. Francis DP; Grohmann G Vaccine; 2011 Jul; 29 Suppl 1():A45-7. PubMed ID: 21684429 [TBL] [Abstract][Full Text] [Related]
13. Technology transfer of an oil-in-water vaccine-adjuvant for strengthening pandemic influenza preparedness in Indonesia. Ventura R; Brunner L; Heriyanto B; de Boer O; O'Hara M; Huynh C; Suhardono M; Collin N Vaccine; 2013 Mar; 31(12):1641-5. PubMed ID: 22884665 [TBL] [Abstract][Full Text] [Related]
14. Live attenuated pandemic influenza vaccine: clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries. Rudenko L; van den Bosch H; Kiseleva I; Mironov A; Naikhin A; Larionova N; Bushmenkov D Vaccine; 2011 Jul; 29 Suppl 1():A40-4. PubMed ID: 21684428 [TBL] [Abstract][Full Text] [Related]
15. Global production capacity of seasonal influenza vaccine in 2011. Partridge J; Kieny MP Vaccine; 2013 Jan; 31(5):728-31. PubMed ID: 23149268 [TBL] [Abstract][Full Text] [Related]
17. Pandemic influenza and the global vaccine supply. Fedson DS Clin Infect Dis; 2003 Jun; 36(12):1552-61. PubMed ID: 12802755 [TBL] [Abstract][Full Text] [Related]
18. Achieving clinical equality in an influenza pandemic: patent realities. Kane EM Seton Hall Law Rev; 2009; 39(4):1137-72. PubMed ID: 20718133 [TBL] [Abstract][Full Text] [Related]
19. The Vaccine Formulation Laboratory: a platform for access to adjuvants. Collin N; Dubois PM Vaccine; 2011 Jul; 29 Suppl 1():A37-9. PubMed ID: 21684427 [TBL] [Abstract][Full Text] [Related]
20. Developing vaccines against pandemic influenza. Wood JM Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1953-60. PubMed ID: 11779397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]